5 studies found for: "Subcutaneous panniculitis-like T-cell lymphoma"
|1||Active, not recruiting||
Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas
CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma
Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma
SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma
Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma
† Indicates status has not been verified in more than two years